Cartesian Therapeutics, Inc. (RNAC) AI Dilution Summary

Cash was $147,606,000 at the 2026-06-30 balance-sheet date, against estimated monthly burn of $7,202,833. The company funds itself through an ATM program with Leerink Partners LLC authorised to $100,000,000. It had sold 93,791 shares under the program since it began, through 2026-06-30; sales after 2026-06-30 are not yet reported.